SE8802176D0 - Fusion protein and its use - Google Patents
Fusion protein and its useInfo
- Publication number
- SE8802176D0 SE8802176D0 SE8802176A SE8802176A SE8802176D0 SE 8802176 D0 SE8802176 D0 SE 8802176D0 SE 8802176 A SE8802176 A SE 8802176A SE 8802176 A SE8802176 A SE 8802176A SE 8802176 D0 SE8802176 D0 SE 8802176D0
- Authority
- SE
- Sweden
- Prior art keywords
- fusion protein
- dna
- hiv
- vector
- carrying
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title abstract 5
- 102000037865 fusion proteins Human genes 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8802176A SE8802176D0 (sv) | 1988-06-10 | 1988-06-10 | Fusion protein and its use |
| EP19890850190 EP0346316A3 (de) | 1988-06-10 | 1989-06-08 | Fusionsprotein sowie dessen Verwendung |
| JP1148169A JPH0272199A (ja) | 1988-06-10 | 1989-06-09 | 融合タンパク質およびその用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8802176A SE8802176D0 (sv) | 1988-06-10 | 1988-06-10 | Fusion protein and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8802176D0 true SE8802176D0 (sv) | 1988-06-10 |
Family
ID=20372584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8802176A SE8802176D0 (sv) | 1988-06-10 | 1988-06-10 | Fusion protein and its use |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0346316A3 (de) |
| JP (1) | JPH0272199A (de) |
| SE (1) | SE8802176D0 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| US7048929B1 (en) * | 1997-11-10 | 2006-05-23 | Dana-Farber Cancer Institute, Inc. | Stabilized primate lentivirus envelope glycoproteins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0198015B2 (de) * | 1984-10-02 | 1995-07-19 | Biogen, Inc. | Herstellung von streptavidinähnlichen polypeptiden |
| GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
-
1988
- 1988-06-10 SE SE8802176A patent/SE8802176D0/xx unknown
-
1989
- 1989-06-08 EP EP19890850190 patent/EP0346316A3/de not_active Withdrawn
- 1989-06-09 JP JP1148169A patent/JPH0272199A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0346316A3 (de) | 1991-07-17 |
| EP0346316A2 (de) | 1989-12-13 |
| JPH0272199A (ja) | 1990-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH0229046H1 (de) | Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech | |
| DK383189D0 (da) | Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer | |
| DE68917323D1 (de) | Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine. | |
| ATE87655T1 (de) | Markierer der t-zelle aktivierung. | |
| DK108189A (da) | Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer | |
| FI962247L (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
| NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
| FI882407L (fi) | Fibrinolytiska proteiner. | |
| NO882917L (no) | Fusjonsproteiner og partikler. | |
| FI841288A7 (fi) | Rekombinaatti-DNA-koodaus polypeptidin ilmaisemiseksi. | |
| DK35189D0 (da) | Forbindelser indeholdende rekombinant dna, vektorer omfattende disse forbindelser samt fremgangsmaade til udtrykkelse af et humant adenocarcinoma-antigen | |
| SE8802176D0 (sv) | Fusion protein and its use | |
| DK723488D0 (da) | Fremgangsmaade til rekombinant udtrykkelse af zymogene former af humant protein c samt vektorer, dna-forbindelser og transformanter til brug ved fremgangsmaaden | |
| FI896261A7 (fi) | Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena | |
| DK0444775T3 (da) | Rekombinant-DNA-ekspressionsvektorer og DNA-forbindelser, som koder for isopenicillin-N-epimerase-ak tivitet | |
| DK533087D0 (da) | Anthracyklinglykosider, deres fremstilling, mellemprodukter deraf samt praeparater indeholdende disse og deres anvendelse | |
| DK416489D0 (da) | Fusionsproteiner, deres fremstilling og anvendelse samt derfor kodende, transformerede, gramnegative bakterier | |
| ES547600A0 (es) | Procedimiento para preparar proteinas encarioticas, procarioticas o viricas. | |
| NO161684C (no) | Endoproteinase-lyste f or utvinning av enzymet, samt anvendelse av enzymet til sekvensbestemmelse av proteiner og peptider. | |
| ATE101199T1 (de) | Rekombinante ligninase. | |
| IL91462A0 (en) | Recombinant fusion proteins and dna encoding for such a protein | |
| DK130290D0 (da) | Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner | |
| DK270386D0 (da) | Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse | |
| DE3888715D1 (de) | Reg-Gen und dadurch kodiertes Protein. | |
| SE8800981D0 (sv) | A recombinant fusion protein, its use and a recombinant vector |